Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet consectetur. Integer eget magna mollis eleifend. Ullamcorper eu mauris luctus amet nullam. Feugiat mi libero lacus in ac magna turpis viverra.

Subscribe to news

We are excited to keep you updated with news tailored to your preferences.

By subscribing to one or more streams, you'll receive information relevant to the areas you've selected. If you ever wish to update your preferences, you can do so at any time.

Latest news

World Bio Markets: AI and Machine Learning - The Silver Bullet we Must Not Dodge

Read more

eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturing

Dr. Paul Opgenorth
Read more

Slack Capital interview: Chris Marlett, Chairman of the Board

Chris Marlett, MDB Capital
Read more

Slack Capital interview: Damien Perriman, CCO

Read more